Reuters logo
BRIEF-Elanix Biotechnologies: non-cash capital increase against contribution in kind
October 17, 2017 / 10:58 AM / 2 months ago

BRIEF-Elanix Biotechnologies: non-cash capital increase against contribution in kind

Oct 17 (Reuters) - ELANIX BIOTECHNOLOGIES AG:

* DGAP-ADHOC: ELANIX BIOTECHNOLOGIES AG: AGREEMENT IN PRINCIPLE REACHED ON THE CONDITIONS FOR A NON-CASH CAPITAL INCREASE AGAINST A CONTRIBUTION IN KIND FOR THE PROGENITOR BONE CELL BANK FROM INNO 4 CELL AG

* ‍AT THIS TIME, COMPANY VALUATION AND DUE DILIGENCE OF INNO 4 CELL AG HAVE NOT BEEN COMPLETED​

* ‍VALUATION OF TRANSACTION IS EXPECTED TO BE IN RANGE OF EUR 10.5 M TO EUR 12.5 M​

* ‍ISSUE PRICE OF NEW SHARES HAS YET TO BE DETERMINED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below